These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232 [TBL] [Abstract][Full Text] [Related]
4. Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease. Addi T; Dou L; Burtey S Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322010 [TBL] [Abstract][Full Text] [Related]
5. Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review. Harlacher E; Wollenhaupt J; Baaten CCFMJ; Noels H Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008960 [TBL] [Abstract][Full Text] [Related]
6. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins. Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D Nephron; 2017; 137(1):1-7. PubMed ID: 28490014 [TBL] [Abstract][Full Text] [Related]
7. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight. Chao CT; Lin SH Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937 [TBL] [Abstract][Full Text] [Related]
8. Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease. Diaz-Ricart M; Torramade-Moix S; Pascual G; Palomo M; Moreno-Castaño AB; Martinez-Sanchez J; Vera M; Cases A; Escolar G Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32492843 [TBL] [Abstract][Full Text] [Related]
9. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease. Wu CL; Tarng DC Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312 [TBL] [Abstract][Full Text] [Related]
10. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees. Rapp N; Evenepoel P; Stenvinkel P; Schurgers L Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33003628 [TBL] [Abstract][Full Text] [Related]
11. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization. Filipska I; Winiarska A; Knysak M; Stompór T Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096 [TBL] [Abstract][Full Text] [Related]
12. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them? Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928 [TBL] [Abstract][Full Text] [Related]
13. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease. Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039 [TBL] [Abstract][Full Text] [Related]
14. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients. Ito S; Yoshida M Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478 [TBL] [Abstract][Full Text] [Related]